CSIMarket
 


Watson Pharmaceuticals Inc  (WPI)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
   Industry Legacy
   Sector  Consumer Non Cyclical
 
 

WPI's vs. Competition, Income Growth by Segments

(Income Q 3 Growth Rates)



COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products - -
Abbott Laboratories ABT Synthroid - -
Eli Lilly And Company LLY Endocrinology - -
Eli Lilly And Company LLY Oncology - -
Eli Lilly And Company LLY Cardiovascular - -
Johnson and Johnson JNJ PROCRIT - -
Johnson and Johnson JNJ Other - -
Mylan N v MYL Total -8.08 % 4.64 %
Pfizer Inc PFE Urology - -
Pfizer Inc PFE Oncology - -
Waters Corp WAT Total 0.25 % 7.52 %
Amgen Inc AMGN NeulastaTM-International - -
Amgen Inc AMGN NeulastaTM-U.S. - -
Amgen Inc AMGN Aranesp TM-International - -
Amgen Inc AMGN NEUPOGEN TM-International - -
Amgen Inc AMGN Aranesp TM-U.S. - -
Amgen Inc AMGN EPOGEN TM - -
Amgen Inc AMGN NEUPOGEN TM-U.S. - -
Amgen Inc AMGN Sensipar TM - -
Bristol Myers Squibb Co BMY SPRYCEL - -
Merck and Co Inc MRK Zetia - -
Merck and Co Inc MRK Januvia - -
Celgene Corp CELG ABRAXANE - -
Actavis Plc ACT Branded pharmaceutical products - -
Abbvie Inc ABBV Synthroid - -
Johnson and Johnson JNJ VELCADE - -
Actavis Plc ACT Urology and Gastroenterology - -
APROX. MARKET   SUBTOTAL -14.1 % -4.84 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Watson Pharmaceuticals Inc WPI Distribution 33.65 % 36.27 %
Actavis Plc ACT Distribution 33.65 % 36.27 %
APROX. MARKET   SUBTOTAL 33.65 % 36.27 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Watson Pharmaceuticals Inc WPI Generic pharmaceutical products 23.14 % -12.12 %
Abbott Laboratories ABT Biaxin clarithromycin - -
Abbott Laboratories ABT Other - -
Bristol Myers Squibb Co BMY PLAVIX - -
Bristol Myers Squibb Co BMY ABILIFY - -
Amgen Inc AMGN Aranesp - -
Eli Lilly And Company LLY Neurosciences - -
Eli Lilly And Company LLY Cardiovascular - -
HOSPIRA, INC. HSP Injectable Pharmaceutical - -
Johnson and Johnson JNJ RISPERDAL - -
Johnson and Johnson JNJ LEVAQUIN / FLOXIN - -
Merck and Co Inc MRK Maxalt - -
Merck and Co Inc MRK Other - -
Mylan N v MYL Total -8.08 % 4.64 %
Pfizer Inc PFE Central nervous system disorders - -
Merck and Co Inc MRK Singulair - -
Bristol Myers Squibb Co BMY Avapro/Avalide - -
Merck and Co Inc MRK CozaarHyzaar - -
Merck and Co Inc MRK Zocor - -
Pfizer Inc PFE Cardiovascular & metabolic diseases - -
Merck and Co Inc MRK Zetia - -
Amgen Inc AMGN Neulasta - -
Actavis Plc ACT Generic pharmaceutical products 23.14 % -12.12 %
Abbvie Inc ABBV Other - -
Johnson and Johnson JNJ INVEGA - -
Bristol Myers Squibb Co BMY Eliquis - -
APROX. MARKET   SUBTOTAL 12.33 % -7.95 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Watson Pharmaceuticals Inc WPI Total 11.08 % -17.27 %
Actavis Plc ACT Total 11.08 % -17.27 %
APROX. MARKET   SUBTOTAL 11.08 % -17.27 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BMEA's Profile

Stock Price

BMEA's Financials

Business Description

Fundamentals

Charts & Quotes

BMEA's News

Suppliers

BMEA's Competitors

Customers & Markets

Economic Indicators

BMEA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071